Federica Saletta
Federica Saletta
Children's Cancer Institute
Verified email at
Cited by
Cited by
XRCC3 and XPD/ERCC2 Single Nucleotide Polymorphisms and the Risk of Cancer: A HuGE Review
M Manuguerra, F Saletta, MR Karagas, M Berwick, F Veglia, P Vineis, ...
American journal of epidemiology 164 (4), 297-302, 2006
Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion
F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ...
Cancer research 80 (19), 4129-4144, 2020
Iron chelators for the treatment of cancer
Y Yu, E Gutierrez, Z Kovacevic, F Saletta, P Obeidy, Y Suryo Rahmanto, ...
Current medicinal chemistry 19 (17), 2689-2702, 2012
A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility
P Vineis, M Manuguerra, FK Kavvoura, S Guarrera, A Allione, F Rosa, ...
Journal of the National Cancer Institute 101 (1), 24-36, 2009
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
DR Carter, J Murray, BB Cheung, L Gamble, J Koach, J Tsang, S Sutton, ...
Science translational medicine 7 (312), 312ra176-312ra176, 2015
Advances in paediatric cancer treatment
F Saletta, MS Seng, LMS Lau
Translational pediatrics 3 (2), 156, 2014
Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia
M Whitnall, YS Rahmanto, MLH Huang, F Saletta, HC Lok, L Gutiérrez, ...
Proceedings of the National Academy of Sciences 109 (50), 20590-20595, 2012
Multi-factor dimensionality reduction applied to a large prospective investigation on gene–gene and gene–environment interactions
M Manuguerra, G Matullo, F Veglia, H Autrup, AM Dunning, S Garte, ...
Carcinogenesis 28 (2), 414-422, 2007
Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1α and p53
F Saletta, YS Rahmanto, E Noulsri, DR Richardson
Molecular pharmacology 77 (3), 443-458, 2010
The translational regulator eIF3a: the tricky eIF3 subunit!
F Saletta, YS Rahmanto, DR Richardson
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 275-286, 2010
N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion
DJR Lane, F Saletta, YS Rahmanto, Z Kovacevic, DR Richardson
PloS one 8 (2), e57273, 2013
Molecular profiling of childhood cancer: Biomarkers and novel therapies
F Saletta, C Wadham, DS Ziegler, GM Marshall, M Haber, G McCowage, ...
BBA clinical 1, 59-77, 2014
Genetic causes of cancer predisposition in children and adolescents
F Saletta, L Dalla Pozza, JA Byrne
Translational pediatrics 4 (2), 67, 2015
Copper: an intracellular achilles’ heel allowing the targeting of epigenetics, kinase pathways, and cell metabolism in cancer therapeutics
F Michniewicz, F Saletta, JRC Rouaen, RV Hewavisenti, D Mercatelli, ...
ChemMedChem 16 (15), 2315-2329, 2021
Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes
F Saletta, YS Rahmanto, AR Siafakas, DR Richardson
Journal of Biological Chemistry 286 (41), 35396-35406, 2011
32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies
A Munnia, F Saletta, A Allione, S Piro, M Confortini, G Matullo, M Peluso
Mutagenesis 22 (6), 381-385, 2007
Expression of DNA repair and metabolic genes in response to a flavonoid-rich diet
S Guarrera, C Sacerdote, L Fiorini, R Marsala, S Polidoro, S Gamberini, ...
British journal of nutrition 98 (3), 525-533, 2007
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells
F Saletta, G Matullo, M Manuguerra, S Arena, A Bardelli, P Vineis
cancer research 67 (15), 7088-7094, 2007
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
K Hsu, S Middlemiss, F Saletta, S Gottschalk, GB McCowage, B Kramer
Cancer Gene Therapy 28 (3), 321-334, 2021
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo
J Murray, E Valli, MT Denise, AM Truong, AJ Gifford, GL Eden, LD Gamble, ...
European Journal of Cancer 83, 132-141, 2017
The system can't perform the operation now. Try again later.
Articles 1–20